MedTrace Logo

Clinical Trial to Evaluate the Efficacy and Safety of Sodium Bemiparin for Treatment of Diabetic Foot Ulcers

NCT00448903 · Status: COMPLETED · Phase: PHASE3 · Type: INTERVENTIONAL · Enrollment: 329

Last updated 2011-03-17

No results posted yet for this study

Summary

Chronic foot ulcers are a common, severe and expensive complication in patients with diabetes and often causes lower-extremity amputation. The aim of this study is to evaluate the effect of bemiparin as treatment of diabetic foot ulcers.

Conditions

  • Foot Ulcer, Diabetic

Interventions

DRUG

Bemiparin

Bemiparin sodium

DRUG

Placebo

Sodium Chloride 0,9%

Sponsors & Collaborators

  • Rovi Pharmaceuticals Laboratories

    lead INDUSTRY

Principal Investigators

  • JR March, MD · Getafe Hospital, E-28905 Getafe (Madrid) Spain

  • J Marinel-lo, MD · Mataró Hospital, E-08304 Mataro (Barcelona) Spain

  • R Gómez Medialdea, MD · Virgen de la Victoria Hospital, E-29010 Malaga, Spain

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2007-03-31
Primary Completion
2009-12-31
Completion
2010-04-30

Countries

  • Croatia
  • Poland
  • Romania
  • Russia
  • Serbia
  • Spain

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00448903 on ClinicalTrials.gov